Theriva™ biologics to participate in the bio-europe conference

Rockville, md., nov. 02, 2023 (globe newswire) -- theriva™ biologics (nyse american: tovx), a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas of high unmet need, today announced that company's management will provide a corporate update and participate in one-on-one meetings at the bio-europe conference, to be held in munich from november 6-8, 2023.
TOVX Ratings Summary
TOVX Quant Ranking